ILS 2007 ANNUAL MEETING

Liposome Advances: Recent Progress in Drug and Vaccine Delivery

School of Pharmacy , University of London,

London, UK

December 8-11, 2007


The ILS is pleased to announce that its 3rd ILS Annual Meeting: Liposome Advances will take place this year between 8-11 of December in London.

The 3rd ILS Annual Meeting will deal with recent developments in liposomology.


Topics will include interaction of liposomes with the biological milieu, application of liposomes in cancer chemotherapy and immunotherapy, liposome-based nucleic acid therapies, liposomal genetic and conventional vaccines, topical therapies, and novel technologies. Plenary lectures will be supplemented with Short Communications and a Poster session.

Invited Speakers include:

Jan Kamps

Netherlands

Targeting liposomes to endothelial cells in inflammation

Beth Goins

 

USA

 

Use of imaging for monitoring liposome distribution and radionuclide therapy

Moein Moghimi

UK

Complement activation by mPEG-liposomes and poly(ethylene glycol)s

Janos Szebeni

Hungary

Reduction of liposome-induced infusion reactions by tolerization.

Alberto Gabizon

 

Israel

 

The liposome-based approach for intracellular drug delivery and > cytotoxicity

Vladimir Torchilin

USA

TBA

John Park

USA

Liposome-based agents: new drug delivery and targeting strategies

Mirco Ponzoni

 

Italy

 

Tumour-targeted liposomal antisense oligonucleotide therapy in neuroblastoma

Andy Janoff

USA

Optimizing combination chemotherapy by controlling drug ratios

Peter Cullis

Canada

The utility of lipid nanoparticle systems for delivery of siRNA

Francis Szoka

USA

TBA

Gert Storm

Netherlands

Liposomal delivery of nucleic acids

 

Gabriel Lopez-Berstein

USA

 

Nanoliposomes delivery of tyrosine kinase inhibitors

 

Volkmar Weissig

USA

Nanovesicles targeting the mitochondrial network

Stephen Hart

UK

Peptide-targeted liposomal formulations for in vivo gene therapy

Mark Tracy

USA

Development of liposomes for the systemic delivery of siRNA

Carl Alving

 

USA

 

Polyreactive antibodies induced by liposomes containing lipid A: Implications for vaccine development

Yvonne Perrie

UK

Cationic liposomes as vaccine adjuvants

Thomas Rades

 

NZ

 

From liposomes to Pluscoms - use of phospholipid based nanoparticles as vaccine delivery systems.

Joke Bouwstra

Netherlands

Transcutaneous vaccination

Rinaldo Zubriggen

 

Switzerland

 

A new and versatile virosomal antigen delivery system to induce cellular and humoural immune responses

Gregory Gregoriadis

UK

TBA

Adi Eisenberg

Canada

Control of structural parameters in block co-polymer vesicles

Yechezkel Barenholz

 

Israel

 

Novel approaches to liposome drug loading: relevance to therapeutic efficacy

Paavo Kinnunen

Finland

Liposomes: from biophysics to drug & gene delivery

Kostas Kostarelos

UK

Liposomes as biomembrane templates of nanomaterials

Felix Goni

Spain

Exploring membrane domain coexistence in liposomes

David Thompson

 

USA

 

Design and performance of acid-sensitive liposomes using vinyl ether lipids with tunable reactivity

Toos Daemen

 

Netherlands

 

A virosome-based therapeutic immunization strategy against cervical cancer and premaligant cervical disease

Gerard Jensen

USA

AmBisome: recent findings and therapeutic index at high dose

Gregor Cevc

 

Germany

 

Functional and biological characteristics of Diractin , the first approved product based on Transfersome technology

Armagan Kocer

Netherlands

Functional membranes for triggered release

Claude Nicolau

France

TBA

Click here to download the ILS 2007 Annual Meeting Registration Form

Click here to download the Meeting Flyer

CALL FOR ABSTRACTS

Submission Deadline: 16 November 2007

Submit your abstracts now to: conferencedec07@btinternet.com

Short presentations will be selected from abstract submissions
ILS Young Investigator Award will be awarded to the best oral presentation

On behalf of the 3rd ILS Annual Meeting Organising Committee: Gregory Gregoriadis, Kostas Kostarelos, Moein Moghimi and Yvonne Perrie.